Yungjin Pharm. Co., Ltd. (003520.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩955 (+1.06%) as of
Key statistics
- Market cap
- 174.66B
- Dividend yield
- 0.00%
- 52-week range
- 944.00 – 2,320.00
- Beta
- 0.71
- Revenue (TTM)
- 179.5B
- Profit margin
- -3.26%
- Volume
- 286.67k
About Yungjin Pharm. Co., Ltd.
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.